<abstract xmlns="http://www.w3.org/1999/xhtml"><p>Gestational hypertension and premature birth frequently and independently affect the pregnancy prognosis with potentially detrimental influence of the pregnancy evolution. Pregnancy-induced hypertension, spectrum and categories of the systemic disease: gestational hypertension, preeclampsia, eclamsia, Hellp syndrome, overlapping preeclampsia (PE) chronic arterial hypertension, are some of the complications that can occur over the pregnancy evolution. Annually, preeclampsia affects approximately 4 million pregnancies. According to ACOG, preeclampsia complicates the evolution of pregnancies in a 2-8% ratio. According to WHO and FIGO, premature birth occurs after 37 weeks of complete amenorrhea (AS) (or 259 days of amenorrhea). A spontaneous premature birth complicates about 5-18% of pregnancies. I emphasize that the two gestational syndromes are intricate because 1/4-1/3 of premature births are associated with preeclampsia. Considered to be an important public health problem, it is important to identify new methods of evaluation, screening and therapy for gestational syndromes, taking into account the risk of increased recurrence of child birth in a subsequent pregnancy.</p></abstract>

Gestational hypertension and premature birth frequently and independently affect the pregnancy prognosis with potentially detrimental influence of the pregnancy evolution. Pregnancy-induced hypertension, spectrum and categories of the systemic disease: gestational hypertension, preeclampsia, eclamsia, Hellp syndrome, overlapping preeclampsia (PE) chronic arterial hypertension, are some of the complications that can occur over the pregnancy evolution. Annually, preeclampsia affects approximately 4 million pregnancies. According to ACOG, preeclampsia complicates the evolution of pregnancies in a 2-8% ratio. According to WHO and FIGO, premature birth occurs after 37 weeks of complete amenorrhea (AS) (or 259 days of amenorrhea). A spontaneous premature birth complicates about 5-18% of pregnancies. I emphasize that the two gestational syndromes are intricate because 1/4-1/3 of premature births are associated with preeclampsia. Considered to be an important public health problem, it is important to identify new methods of evaluation, screening and therapy for gestational syndromes, taking into account the risk of increased recurrence of child birth in a subsequent pregnancy.

Two Great Intricate Gestational Syndromes. New Screening and Treatment Strategies

Acta Medica Transilvanica

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Gestational hypertension and premature birth frequently and independently affect the pregnancy prognosis with potentially detrimental influence of the...

Two Great Intricate Gestational Syndromes. New Screening and Treatment Strategies

Publicado en línea: 23 oct 2020

Páginas: 48 - 50

Recibido: 04 ago 2020

Aceptado: 24 ago 2020

DOI: https://doi.org/10.2478/amtsb-2020-0050

Palabras clave
gestational hypertension, preeclampsia, premature birth, risk of recurrence, screening, prevention, calcium, low dose aspirin, probiotics, PAPP-A, sFlt, sEng-1, PGTF

© 2020 Georgeta Gînfălean, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Two Great Intricate Gestational Syndromes. New Screening and Treatment Strategies

Publicado en línea: 23 oct 2020

Páginas: 48 - 50

Recibido: 04 ago 2020

Aceptado: 24 ago 2020

DOI: https://doi.org/10.2478/amtsb-2020-0050

Palabras clavegestational hypertension, preeclampsia, premature birth, risk of recurrence, screening, prevention, calcium, low dose aspirin, probiotics, PAPP-A, sFlt, sEng-1, PGTF

© 2020 Georgeta Gînfălean, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Palabras clave
gestational hypertension, preeclampsia, premature birth, risk of recurrence, screening, prevention, calcium, low dose aspirin, probiotics, PAPP-A, sFlt, sEng-1, PGTF